Walmart Pharmacy 10-0770 Durable Medical Equipment & Medical Supplies Location: 3503 10th St, Great Bend, Kansas 67530 Phone: (620) 792-5237 |
Walgreens #7818 Durable Medical Equipment & Medical Supplies Location: 3920 10th St, Great Bend, Kansas 67530 Phone: (620) 792-4467 |
Dillon Pharmacy Durable Medical Equipment & Medical Supplies Location: 4107 10th St, Great Bend, Kansas 67530 Phone: (620) 795-2944 |
Medical Park Pharmacy Of Great Bend Community/Retail Pharmacy Location: 1309 Polk St, Great Bend, Kansas 67530 Phone: (620) 792-1221 |
Alternacare Home Health Services In DME Supplier - Oxygen Equipment & Supplies Location: 2708 10th St, Great Bend, Kansas 67530 Phone: (620) 793-3700 |
Advanced Medical Dme Llc Medicare Supplier Location: 3520 Lakin Ave, Great Bend, Kansas 67530 Phone: (620) 797-9242 |
The 10th Street Eyecare Center Medicare Supplier Location: 2601 10th St, Great Bend, Kansas 67530 Phone: (620) 792-2020 |
News Archive
Raydiance Corporation, developer of the world's first commercial-grade ultrafast laser, announced today that its Smart LightTM ultrafast platform will provide the core technology for an advanced laser machining process, Noble UltraLightTM, to be launched by leading contract manufacturer Norman Noble, Inc. The Noble UltraLightTM process will enable highly precise, athermal machining of bio-absorbable materials, shape memory metals and other exotic materials for the medical device industry.
Scientists at Université de Montréal have developed a unique technique to map, on a scale of milliseconds, the elasticity of the components inside a cell.
Researchers believe that stuttering - a potentially lifelong and debilitating speech disorder - stems from problems with the circuits in the brain that control speech, but precisely how and where these problems occur is unknown.
Proliferative vitreoretinopathy (PVR), or the formation of scar tissue within the eye, is a serious, sight-threatening complication in patients recovering surgical repair of retinal detachment. A new study conducted by investigators at the Schepens Eye Research Institute, the Department of Ophthalmology at Harvard Medical School, and the Massachusetts Eye and Ear Infirmary in Boston, published in the December issue of the American Journal of Pathology, suggests that a cocktail containing reagents to neutralize a relatively small subset of vitreal growth factors and cytokines may be an effective treatment.
At bottom, the recent deal was meant to defer the bedrock choices that need another election or two to resolve while making incremental progress. So the current exercise is about rooting out $1.5 trillion in "savings," which will mean a hodgepodge of changes at the margin, not a rewrite of either entitlements or taxes. If bigger change were possible, Speaker John Boehner and President Obama would have agreed to it.
› Verified 4 days ago